STOCK TITAN

Form 4: FOEHR MATTHEW W reports multiple insider transactions in OABI

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

FOEHR MATTHEW W reported multiple insider transaction types in a Form 4 filing for OABI. The filing lists transactions totaling 93,670 shares at a weighted average price of $1.70 per share. Following the reported transactions, holdings were 4,375,787 shares.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
FOEHR MATTHEW W

(Last) (First) (Middle)
5980 HORTON STREET, STE 600

(Street)
EMERYVILLE CA 94608

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
OmniAb, Inc. [ OABI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President and CEO
3. Date of Earliest Transaction (Month/Day/Year)
02/16/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/16/2026 M 36,458(1) A $0(2) 4,396,541 D
Common Stock 02/17/2026 S 20,754(3) D $1.7(4) 4,375,787 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (2) 02/16/2026 M 36,458 (1) (1) Common Stock 36,458 $0 247,918 D
Explanation of Responses:
1. Represents the vesting of an RSU grant which occurs in three substantially equal annual installments beginning on February 16, 2025.
2. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
3. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell-to-cover" transaction and do not represent discretionary trades by the reporting person.
4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.68 to $1.79. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Remarks:
By: /s/ Charles S. Berkman, Attorney-in-Fact for Matthew W. Foehr 02/17/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did OmniAb (OABI) CEO Matthew Foehr report?

Matthew Foehr reported RSU vesting and a related share sale. 36,458 RSUs vested and converted into common stock, and 20,754 shares were sold in open-market transactions primarily to satisfy tax withholding obligations tied to that vesting.

How many OmniAb (OABI) shares does the CEO own after this Form 4?

After the reported transactions, Matthew Foehr directly holds 4,375,787 shares of OmniAb common stock and 247,918 Restricted Stock Units. RSUs represent rights to receive additional shares upon future vesting, subject to the company’s equity incentive plan terms.

Was the OmniAb (OABI) CEO’s share sale a discretionary trade?

The filing states the 20,754-share sale was not discretionary. It was a mandated "sell-to-cover" transaction under OmniAb’s equity incentive plans to fund tax withholding obligations arising from the vesting of the CEO’s RSUs.

At what price were OmniAb (OABI) shares sold in the CEO’s Form 4?

The Form 4 reports a weighted average price of $1.70 per share for the sale of 20,754 shares. The filing notes these sales occurred in multiple trades at prices ranging from $1.68 to $1.79 per share.

What does the RSU vesting in OmniAb (OABI) CEO’s filing represent?

The 36,458 RSUs that vested represent part of an equity grant vesting in three substantially equal annual installments beginning February 16, 2025. Each RSU corresponds to the right to receive one share of OmniAb common stock upon vesting.
OmniAb, Inc.

NASDAQ:OABI

OABI Rankings

OABI Latest News

OABI Latest SEC Filings

OABI Stock Data

244.72M
106.07M
Biotechnology
Services-commercial Physical & Biological Research
Link
United States
EMERYVILLE